It is obvious from literature that IL13α2R is promising target for chemotherapy cytotoxic drugs, i.e. to guide liposomes to the glioblastoma tumor site to cope with overexpressed IL13α2R receptors, doxorubicin loaded liposomes functionalized with IL-13 were fabricated and evaluated. This evidence concerns the gene IL13 and neoplasm.